Found 2 hits Enz. Inhib. hit(s) with Target = 'Apoptosis regulator Bcl-2' and Ligand = 'BDBM189770' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Apoptosis regulator Bcl-2
(Homo sapiens (Human)) | BDBM189770
(US11369599, Compound 341 | US9174982, 341)Show SMILES CC1(O)CCC(COc2ncc(cc2Cl)S(=O)(=O)NC(=O)c2ccc(cc2Oc2cnc3[nH]ccc3c2)N2CCN(CC3=C(CC4(CC4)CC3)c3ccc(Cl)cc3)CC2)CC1 |t:46,(2.84,-15.44,;4.2,-14.72,;2.84,-14,;4.97,-16.05,;6.51,-16.05,;7.28,-14.72,;8.82,-14.72,;9.59,-13.39,;11.13,-13.39,;11.9,-12.05,;13.44,-12.05,;14.21,-13.39,;13.44,-14.72,;11.9,-14.72,;11.13,-16.05,;15.75,-13.39,;15.75,-14.93,;15.75,-11.85,;17.29,-13.39,;18.06,-12.05,;19.6,-12.05,;17.29,-10.72,;15.75,-10.72,;14.98,-9.39,;15.75,-8.05,;17.29,-8.05,;18.06,-9.39,;19.6,-9.39,;20.37,-8.05,;19.6,-6.72,;20.37,-5.38,;21.91,-5.38,;22.94,-4.24,;24.34,-4.87,;24.18,-6.4,;22.68,-6.72,;21.91,-8.05,;14.98,-6.72,;13.44,-6.72,;12.67,-5.38,;13.44,-4.05,;12.67,-2.72,;11.13,-2.72,;10.36,-1.38,;8.82,-1.38,;8.05,-2.72,;6.71,-3.49,;6.71,-1.95,;8.82,-4.05,;10.36,-4.05,;11.13,-.05,;10.36,1.28,;11.13,2.62,;12.67,2.62,;13.44,3.95,;13.44,1.28,;12.67,-.05,;14.98,-4.05,;15.75,-5.38,;6.51,-13.39,;4.97,-13.39,)| Show InChI InChI=1S/C46H50Cl2N6O6S/c1-45(56)12-8-30(9-13-45)29-59-44-40(48)24-37(27-51-44)61(57,58)52-43(55)38-7-6-35(23-41(38)60-36-22-32-11-17-49-42(32)50-26-36)54-20-18-53(19-21-54)28-33-10-14-46(15-16-46)25-39(33)31-2-4-34(47)5-3-31/h2-7,11,17,22-24,26-27,30,56H,8-10,12-16,18-21,25,28-29H2,1H3,(H,49,50)(H,52,55) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| US Patent
| <0.0100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description The inhibition constant (Ki) for binding of representative compounds to Bcl-2 protein, as determined by a TR-FRET (Time-Resolved Fluorescence-Resonan... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q21V5J59 |
More data for this Ligand-Target Pair | |
Apoptosis regulator Bcl-2
(Homo sapiens (Human)) | BDBM189770
(US11369599, Compound 341 | US9174982, 341)Show SMILES CC1(O)CCC(COc2ncc(cc2Cl)S(=O)(=O)NC(=O)c2ccc(cc2Oc2cnc3[nH]ccc3c2)N2CCN(CC3=C(CC4(CC4)CC3)c3ccc(Cl)cc3)CC2)CC1 |t:46,(2.84,-15.44,;4.2,-14.72,;2.84,-14,;4.97,-16.05,;6.51,-16.05,;7.28,-14.72,;8.82,-14.72,;9.59,-13.39,;11.13,-13.39,;11.9,-12.05,;13.44,-12.05,;14.21,-13.39,;13.44,-14.72,;11.9,-14.72,;11.13,-16.05,;15.75,-13.39,;15.75,-14.93,;15.75,-11.85,;17.29,-13.39,;18.06,-12.05,;19.6,-12.05,;17.29,-10.72,;15.75,-10.72,;14.98,-9.39,;15.75,-8.05,;17.29,-8.05,;18.06,-9.39,;19.6,-9.39,;20.37,-8.05,;19.6,-6.72,;20.37,-5.38,;21.91,-5.38,;22.94,-4.24,;24.34,-4.87,;24.18,-6.4,;22.68,-6.72,;21.91,-8.05,;14.98,-6.72,;13.44,-6.72,;12.67,-5.38,;13.44,-4.05,;12.67,-2.72,;11.13,-2.72,;10.36,-1.38,;8.82,-1.38,;8.05,-2.72,;6.71,-3.49,;6.71,-1.95,;8.82,-4.05,;10.36,-4.05,;11.13,-.05,;10.36,1.28,;11.13,2.62,;12.67,2.62,;13.44,3.95,;13.44,1.28,;12.67,-.05,;14.98,-4.05,;15.75,-5.38,;6.51,-13.39,;4.97,-13.39,)| Show InChI InChI=1S/C46H50Cl2N6O6S/c1-45(56)12-8-30(9-13-45)29-59-44-40(48)24-37(27-51-44)61(57,58)52-43(55)38-7-6-35(23-41(38)60-36-22-32-11-17-49-42(32)50-26-36)54-20-18-53(19-21-54)28-33-10-14-46(15-16-46)25-39(33)31-2-4-34(47)5-3-31/h2-7,11,17,22-24,26-27,30,56H,8-10,12-16,18-21,25,28-29H2,1H3,(H,49,50)(H,52,55) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| US Patent
| <0.0100 | <-62.8 | n/a | n/a | n/a | n/a | n/a | n/a | 25 |
ABBVIE INC.; GENENTECH, INC.; THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
US Patent
| Assay Description Representative compounds were serially diluted in dimethyl sulfoxide (DMSO) starting at 50 uM (2x starting concentration; 10% DMSO) and 10 uL were tr... |
US Patent US9174982 (2015)
BindingDB Entry DOI: 10.7270/Q2RB73D5 |
More data for this Ligand-Target Pair | |